Stay updated on Pembrolizumab +/- Radiation in Adenoid Cystic Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab +/- Radiation in Adenoid Cystic Carcinoma Clinical Trial page.

Latest updates to the Pembrolizumab +/- Radiation in Adenoid Cystic Carcinoma Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedAdded a dedicated Locations section with Massachusetts as a site and removed the old Massachusetts Locations header and the HHS Vulnerability Disclosure link due to content reorganization.SummaryDifference0.2%

- Check19 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedMinor page revision updated from v3.3.1 to v3.3.2; no changes to study content, eligibility criteria, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check40 days agoChange DetectedThe Publications section is clarified to indicate that entries are automatically filled from PubMed and may not be about the study, and the page revision is updated to v3.3.1 (from v3.2.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check48 days agoChange DetectedNotice about government funding status has been removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check62 days agoChange DetectedNo substantive differences observed between the screenshots; study details such as eligibility criteria, interventions, and outcomes appear unchanged.SummaryDifference0.4%

- Check90 days agoChange DetectedCore content updated with a new disease term and a new version, plus a critical operating-status notice; an old disease term and prior version were removed.SummaryDifference3%

Stay in the know with updates to Pembrolizumab +/- Radiation in Adenoid Cystic Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab +/- Radiation in Adenoid Cystic Carcinoma Clinical Trial page.